Literature DB >> 20542469

Angiotensin-receptor blockers and cancer: urgent regulatory review needed.

Steven E Nissen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20542469     DOI： 10.1016/S1470-2045(10)70142-X

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  9 in total

1.  Is there a link between angiotensin receptor blockers and cancer?

Authors:  Frank Enseleit; Frank Ruschitzka
Journal:  Curr Hypertens Rep       Date:  2011-02       Impact factor: 5.369

Review 2.  Preventing the aortic complications of Marfan syndrome: a case-example of translational genomic medicine.

Authors:  Alain Li-Wan-Po; Bart Loeys; Peter Farndon; David Latham; Caroline Bradley
Journal:  Br J Clin Pharmacol       Date:  2011-07       Impact factor: 4.335

Review 3.  Angiotensin inhibition and longevity: a question of hydration.

Authors:  Simon N Thornton
Journal:  Pflugers Arch       Date:  2010-12-17       Impact factor: 3.657

4.  Meta-analysis concludes angiotensin receptor blocker use increases the risk of developing cancer: concerns about the science and the message.

Authors:  Michael J Bloch; Jan N Basile
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-08-24       Impact factor: 3.738

5.  Long-term use of antihypertensive medications, hypertension and colorectal cancer risk and mortality: a prospective cohort study.

Authors:  Yin Zhang; Mingyang Song; Andrew T Chan; Jeffrey A Meyerhardt; Walter C Willett; Edward L Giovannucci
Journal:  Br J Cancer       Date:  2022-09-22       Impact factor: 9.075

6.  Angiotensin receptor blockers, cancer, and smoking.

Authors:  Iñaki Marina; Lawrence R Krakoff
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-12       Impact factor: 3.738

7.  ARBs and possible cancer risk.

Authors:  J Aalbers
Journal:  Cardiovasc J Afr       Date:  2010 Jul-Aug       Impact factor: 1.167

8.  Opinions in hypertension. ARBs and risk of cancer: international and South African expert comment.

Authors:  C Lombard; A Nosworthy; J Albers
Journal:  Cardiovasc J Afr       Date:  2010 Nov-Dec       Impact factor: 1.167

9.  Risk of cancer with angiotensin-receptor blockers increases with increasing cumulative exposure: Meta-regression analysis of randomized trials.

Authors:  Ilke Sipahi
Journal:  PLoS One       Date:  2022-03-02       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.